About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Equity
Equity Analysis
Price
Gainers & Losers
Weekly Gainers & Losers
Monthly Gainers & Losers
Out & Under Performers
Advances & Declines
New Highs & Lows
52 Week Highs & Lows
Weightage
Only Buyers & Sellers
Historical Returns
Volume
Volume
Value
Block Deals
Bulk Deals
Highest & Lowest Delivery
Analysis
5 Day's Up & Down
Contribution to Index
Live Indices
Rising VDP
Rising VD & Falling Price
Price Shockers
Volume Shockers
Delivery Shockers
Sector Watch
Exchange Holidays
Exchange Holidays
Mcap Gainers & Losers
News Analysis
Hot Stocks
Opening Bell
Midday Review
Closing Bell
Other Market
Corporate News
Market Pulse
Economy
Company Result
FII Position
Corporate Action
Book Closure
Board Meetings
Bonus Issues
Right Issues
Split of Face Value
Dividend Details
Delisted Companies
Change of Name
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Share holdings
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Annoucements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Insider trading
Other Market
FII Activities
DII Investments
Derivatives Investments
Global Indices
ADR Prices
HOME
>
Equity HOME
>
Equity Analysis
>
Analysis
>
Rising VD & Falling Price
BSE
Rising VD
& Falling Price
Switch to
NSE
Switch to
BSE
28-Apr-2026 15:59
Company Name
23-Apr-2026
Traded Qty
Del.Volume
Price
24-Apr-2026
Traded Qty
Del.Volume
Price
27-Apr-2026
Traded Qty
Del.Volume
Price
Fall in price
%
Rudra Ecovation
70781
70781
22.50
98075
98075
22.29
139150
139150
22.15
-1.56
Shetron
3730
2576
107.33
10028
6114
95.44
19935
14506
91.41
-14.83
Venus Remedies
4624
4247
998.60
8797
7942
948.70
19422
15668
938.05
-6.06
Regal Entertainment
4613
4613
17.44
6415
6415
16.57
34581
34581
15.75
-9.69
Medicamen Biotech
1186
1169
257.10
1294
1201
256.40
1687
1364
253.20
-1.52
Madala Holdings
14
9
200.90
60
50
197.95
95
92
196.95
-1.97
Cerebra Integ. Tech
18316
18316
4.94
31954
31954
4.70
62478
62478
4.47
-9.51
GeeCee Ventures
18
17
301.05
103
100
299.35
775
769
295.50
-1.84
Anuroop Packaging
3406
2312
12.38
5546
5109
12.02
34525
19786
11.49
-7.19
AB Cotspin India
8811
8790
388.90
18562
14792
311.15
187834
130701
248.95
-35.99
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
|
UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.